Anxiety disorders

Christopher K. Varley; Angeles Diaz-Caneja; Elena Garralda

doi:10.1017/CBO9780511544392.059

57 - Anxiety disorders

from Part III - Specific treatments

Published online by Cambridge University Press: 12 May 2010

Christopher K. Varley ,

Angeles Diaz-Caneja and

Elena Garralda

Edited by

Peter Tyrer and

Kenneth R. Silk

Show author details

Christopher K. Varley: Affiliation:
Department of Child and Adolescent Psychiatry University of Washington School of Medicine Seattle, WA USA
Angeles Diaz-Caneja: Affiliation:
Wolverton Gardens Child and Family Consultation Service London UK
Elena Garralda: Affiliation:
Imperial College London Academic Unit of Child and Adolescent Psychiatry St Mary's Campus Norfolk Place London UK
Peter Tyrer: Affiliation:
Imperial College of Science, Technology and Medicine, London
Kenneth R. Silk: Affiliation:
University of Michigan, Ann Arbor

Book contents

Get access

Summary

Editor's note

Treatment of anxiety disorders in children and adolescence is dominated by treatment with cognitive-behavioural therapy or with techniques from cognitive-behavioral therapy. These types of therapies are the first-line treatments among youth with a variety of anxiety disorders including school phobia, elective mutism, PTSD, social phobia, generalized anxiety disorder, panic disorder and obsessive-compulsive disorder. As the disorders become more severe, then medications are recommended, but psychopharmacologic treatment in children is not as widely encouraged as in adults. Also, given that the SSRIs are, in general, the major class used in the treatment of anxiety disorders, and given that there are concerns with respect to suicidal ideation and acts among young people on SSRIs, these pharmacologic interventions are not viewed as first-line treatments. And yet there is much more methodologically sound evidence for pharmacologic treatment than for CBT. The best data we have, for both behavioural/cognitive behavioural as well as psychopharmacological intervention is, with obsessive-compulsive disorder.

Introduction

Anxiety disorders are common in childhood occurring in 3%–13% of all children and adolescents (Anderson et al., 1987; Costello & Angold, 1995; Kashani & Orvashel, 1990). Children typically present with more than one anxiety disorder. Co-morbidity, primarily with depression, is common. Anxiety disorders are associated with significant impairments in multiple functional domains (Costello et al., 1999; Klein & Pine, 2002). Since anxiety disorders may persist into adulthood (Pine et al., 1998), effective treatment is important.

Type: Chapter
Information: Cambridge Textbook of Effective Treatments in Psychiatry , pp. 830 - 840

DOI: https://doi.org/10.1017/CBO9780511544392.059 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Albano, A. M., Marten, P. A., Holt, C. S., Heimberg, R. G. & Barlow, D. H. (1995). Cognitive behavioural group treatment for social phobia in adolescents. A preliminary study. Journal of Nervous and Mental Disease, 183(10), 649–56.Google Scholar

American Academy of Child and Adolescent Psychiatry (AACAP) (1997). Practice parameters for the assessment and treatment of children with anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 36 (Suppl.), S4–26.

American Academy of Child and Adolescent Psychiatry (1998a). Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 37 (Suppl.), S27–45.

American Academy of Child and Adolescent Psychiatry (1998b). Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 37 (Suppl.), S4–26.

Anderson, D. J., Williams, S., McGee, R. & Silva, P. A. (1987). DSM-III disorders in preadolescent children: prevalence in large sample from the general population. Archives of General Psychiatry, 44, 69–76.Google Scholar

Barret, P. M., Dadds, M. R. & Rapee, R. M. (1996). Family management of childhood anxiety: a controlled trial. Journal of Consulting and Clinical Psychology, 65, 366–80.Google Scholar

Barret, P., Healy-Farrell, L. & March, J. (2004). Cognitive-behavioural family treatment of childhood obsessive-compulsive disorder: a controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 46–62.Google Scholar

Beidel, D. C. & Turner, S. M. (1998). Shy Children, Phobic Adults: Nature and Treatment of Social Phobia. Washington, DC: American Psychological Association.

Beidel, D. C., Turner, S. M. & Morris, T. L. (2000). Behavioural treatment of childhood social phobia. Journal of Consulting Clinical Psychology, 68, 1072–80.Google Scholar

Benazon, N. R., Ager, J. & Rosenberg, D. R. (2002). Cognitive behaviour therapy in treatment-naïve children and adolescents with obsessive-compulsive disorder: an open trial. Behaviour Research and Therapy, 40(5), 529–539.Google Scholar

Berney, T., Kolvin, I., Bhate, S. R.et al. (1981). School phobia: a therapeutic trial with clomipramine and short term outcome. British Journal of Psychiatry, 138, 110–18.Google Scholar

Bernstein, G. A., Garfinkel, B. D. & Borchardt, C. M. (1990). Comparative studies of pharmacotherapy for school refusal. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 773–81.Google Scholar

Bernstein, G. A., Borchardt, C. M., Perwien, A. R.et al. (2000). Imipramine plus cognitive-behavioural therapy in the treatment of school refusal. Journal of Child and Adolescent Psychiatry, 39(3), 276–83.Google Scholar

Bernstein, G. A., Hektner, J. M., Borchardt, C. M. & McMillan, M. H. (2001). Treatment of school refusal: one-year follow-up. Journal of Child and Adolescent Psychiatry, 40(2), 206–13.Google Scholar

Birmaher, B., Axelson, D. A., Monk, K.et al. (2003). Fluoxetine for treatment of childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 415–23.Google Scholar

Black, B. & Uhde, T W. (1994). Treatment of elective mutism with Fluoxetine: A double-blind placebo-controlled study. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 1000–6.Google Scholar

Black, B., Uhde, T. W. & Tancer, M. E. (1992). Fluoxetine for the treatment of social phobia. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 36–44.Google Scholar

Blagg, N. R. & Yule, W. (1984). The behavioural treatment of school refusal. Behavioural Research Therapy, 22, 119–27.Google Scholar

Carr, A. (ed) (2000). What Works with Children and Adolescents? A Critical Review of Psychological Interventions with Children, Adolescents and Their Families. London: Routledge.

Celano, M., Hazzard, A., Webb, C. & McCall, C. (1996). Treatment of traumagenic beliefs among sexually abused girls and their mothers: an evaluation study. Journal of Abnormal Child Psychology, 24, 1–17.Google Scholar

Chemtob, C, M., Nakashima, J. & Carlson, J. G. (2002). Brief treatment for elementary school children with disaster-related posttraumatic stress disorder: a field study. Journal of Clinical Psychology, 58, 99–112.Google Scholar

Cohen, J. A. & Mannarino, A. P. (1996). A treatment study for sexually abused preschool children: initial findings. Journal of the American Academy Child and Adolescent Psychiatry, 35, 42–50.Google Scholar

Cohen, J. A. & Mannarino, A. P. (1997). A treatment study of sexually abused preschool children: outcome during 1-year follow-up. Journal of the American Academy Child and Adolescent Psychiatry, 36, 1228–35.Google Scholar

Cohen, J. A., Berliner, L. & March, J. S. (2000). Treatment of children and adolescents. In Effective Treatments for PTSD, ed. Foa, E. B., Keane, T. M. & Friedman, M. J., pp. 106–39. New York: Guilford Press.

Cohen, J. A., Berliner, L. & Mannarino, A. P. (2003). Psychosocial and pharmacological interventions for child crime victims. Journal of Traumatic Stress, 16(2), 175–86.Google Scholar

Cohen, J., Deblinger., E, Mannarino, A. P. & Steer, R. A. (2004). A multisite, randomised controlled trial for children with sexual abuse-related PTSD symptoms. Journal of the American Academy of Child and Adolescent Psychiatry, 43(4), 393–402.Google Scholar

Cordioli, A., Heldt, E., Bochi, D. B.et al. (2003). Cognitive-behavioural group therapy in obsessive-compulsive disorder: a randomised clinical trial. Psychotherapy and Psychosomatics, 72, 211.Google Scholar

Costello E. & Angold A. (1995). Epidemiology. In Anxiety Disorders in Children and Adolescents, ed. March, J., pp. 109–24. New York: Guilford Press.

Costello, E. J., Angold, A. & Keeler, G. P. (1999). Adolescent outcomes of childhood disorders: the consequences of severity and impairment. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 121–8.Google Scholar

Deblinger, E., Lippman, J. & Steer, R. (1996). Sexually abused children suffering post-traumatic stress symptoms: initial treatment outcome findings. Child Maltreatment, 1, 310–21.Google Scholar

Deblinger, E., Steer, R. & Lippmann, J. (1999). Two-year follow-up study of cognitive behavioural therapy for sexually abused children suffering post-traumatic stress symptoms. Child Abuse and Neglect, 23, 1371–8.Google Scholar

Dummit, E. S., Klein, R. G., Asche, B., Martin, J. & Tancer, N. K. (1996). Fluoxetine treatment of children with selective mutism: an open trial. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 615–21.Google Scholar

Emslie, G., Walkup, J., Pliszka, S. & Ernst, M. (1999). Nontricyclic antidepressants: current trends in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 38(5), 517–28.Google Scholar

Flament, M., Rapoport, J. L., Beg, C.et al. (1985). Clomipramine treatment of childhood obsessive-compulsive disorder, Archives of General Psychiatry, 42, 977–88.Google Scholar

Flannery-Schroeder, E. & Kendall, P. C. (2000). Group versus individual cognitive-behavioural treatment for youth with anxiety disorders: a randomised clinical trial. Cognitive Therapy and Research, 3, 251–78.Google Scholar

Franklin, M., Kozak, M., Cashman, L., Coles, M., Rheingold, A. & Foa, E. (1998). Cognitive-behavioural treatment of paediatric obsessive-compulsive disorder: an open clinical trial. Journal of American Academy of Child and Adolescent Psychiatry, 37(4), 412–19.Google Scholar

Gallagher-Heather, M., Rabbin, B. A. & McCloskey, M. S. (2004). A brief group cognitive-behavioural intervention for social phobia in childhood. Journal of Anxiety Disorders, 18(4), 459–79.Google Scholar

Geller, D., Biederman, J., Stewart, E.et al. (2003). Which SSRI? A meta-analysis of pharmacotherapy trials in paediatric obsessive compulsive disorder. American Journal of Psychiatry, 160, 1919–28.Google Scholar

Geller, D. A., Wagner, K. D. & Emslie, G. (2004). Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomised, multicenter, double-blind, placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 1387–96.Google Scholar

Gittelman-Klein, R. & Klein, D. F. (1971). Controlled imipramine treatment of school phobia. Archives of General Psychiatry, 25, 199–215.Google Scholar

Graee, F., Milner, J., Rizzotto, L. & Klein, R. (1994). Clonazepam in childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 372–6.Google Scholar

Kashani, H. & Orvashel, H. (1990). A community study of anxiety in children and adolescents. American Journal of Psychiatry, 147, 313–18.Google Scholar

Kendall, P. (1994). Treating anxiety disorders in children: results of a randomised clinical trial. Journal of Consulting and Clinical Psychology, 62 (1), 100–10.Google Scholar

Kendall, P. C., Flannery-Schroeder, E. & Panichelli-Mindel, S. M.et al. (1997). Therapy for youths with anxiety disorders: a second randomised clinical trial. Journal of Consulting and Clinical Psychology, 65(3), 366–80.Google Scholar

King, N., Tonge, B., Heyne, D.et al. (1998). Cognitive behavioural treatment of school-refusing children: a controlled evaluation. Journal of the American Academy of Child and Adolescent Psychiatry, 37(4), 395–403.Google Scholar

King, N, Tange, J., Mullen, B. J., , P.et al. (2000). Treating sexually abused children with posttraumatic stress symptoms: a randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 1347–55.Google Scholar

Klein, R. G. & Pine, D. S. (2002). Anxiety disorders. In Child and Adolescent Psychiatry: Modern Approaches, ed. Rutter, M. & Taylor, E., 4th edn. London: Blackwell Science Ltd.

Klein, R. G., Kopelwicz, H. S. & Kanner, A. (1992). Imipramine treatment in children with separation anxiety. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 21–8.Google Scholar

Labellarte, M. J., Ginsburg, G. S., Walkup, J. T. & Riddle, M. A. (1999). The treatment of anxiety disorders in children and adolescents. Society of Biological Psychiatry, 46, 1567–78.Google Scholar

Leonard, H. L., Swedo, S. E., Rapaport, J. L.et al. (1989). Treatment of obsessive-compulsive disorder with clomipramine and Desipramine in children and adolescents: a double-blind crossover comparison. Archives of General Psychiatry, 46, 1088–92.Google Scholar

Liebowitz, M. R., Turner, S. M., Piacentini, J. (2002). Fluoxetine in children and adolescents with OCD: a placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1431–8.Google Scholar

Manassis, K., Mendlowitz, S. L., Scapillato, D.et al. (2002). Group and individual cognitive-behavioural therapy for childhood anxiety disorders: a randomised trial. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1423–30.Google Scholar

Mancini, C., Van-Ameringen, M., Oakman, R. & Farvolden, P. (1999). Serotonergic agents in the treatment of social phobia in children and adolescents: a case series. Depression and Anxiety, 10(1), 33–9.Google Scholar

March, J. S., Amaya-Jackson, L., Murray, M. D., Cathryn, M. & Schulte, A. (1998a). Cognitive behavioural psychotherapy for children and adolescents with posttraumatic stress disorder after a single incident stressor. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 585–93.Google Scholar

March, J. S., Biederman, J., Wolkow, R.et al. (1998b). Sertraline in children and adolescents with obsessive-compulsive disorder: a multi-center randomized controlled trial. Journal of the American Medical Association, 280(20), 1752–6.Google Scholar

MHRA (2004). Advice on SSRIs in Children from the Committee on Safety in Medicine. February 12, 2004. Available at: http://medicines.mhra.gov.uk/aboutagency/regframework/csm/csmhome.htm.

Piacentini, J., Bergman, R. L., Jacobs, C., McCracken, J. T. & Kretchman, J. (2002). Open trial of cognitive behaviour therapy for childhood obsessive-compulsive disorder. Journal of Anxiety Disorders, 16(2), 207–19.Google Scholar

Pine, D. S., Cohen, P., Gurley, D., Brook, J. & Ma, Y. (1998). The risk for early adulthood anxiety and depressive disorders in anxiety and depressive disorders. Archives of General Psychiatry, 55, 56–64.Google Scholar

Renaud, J., Birmaher, B., Wassick, S. C. & Bridge, J. (1999). Use of selective serotonin reuptake inhibitors for the treatment of childhood panic disorder: a pilot study. Journal of Child and Adolescent Psychopharmacology, 9(2), 73–83.Google Scholar

Research Unit on Paediatric Psychopharmacology Anxiety Study Group (RUPPS) (2001). Fluvoxamine for the treatment of anxiety disorders in children and adolescents. New England Journal of Medicine, 344(17), 1279–85.

Research Unit of Paediatric Psychopharmacology Anxiety Study Group (RUPPS) (2002). Treatment of paediatric anxiety disorders: an open label extension of the research units on paediatric psychopharmacology anxiety study. Journal of Child and Adolescent Psychopharmacology, 12(3), 175–88.

Riddle, M. A., Scahill, L., King, R. A.et al. (1992). Double-blind crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. Journal of American Academy of Child and Adolescent Psychiatry, 31, 1062–9.Google Scholar

Riddle, M. A., Claghorn J. & Gaffney, G. (1996). Fluvoxamine for children and adolescents with OCD: a controlled multi-center trial. Presented at the 43rd Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Philadelphia, October.

Robert, R., Blakeney, P. E., Villarreal, C., Rosenberg, L. & Meyer, W. J. (1999). Imipramine treatment in pediatric burn patients with symptoms of acute stress disorder: a pilot study. Journal of the American Academy Child and Adolescent Psychiatry, 38(7), 873–82.Google Scholar

Roy-Byrne, P. P. & Cowley, D. S. (2002). Pharmacological treatments for panic disorder, generalized anxiety disorder, specific phobia and social anxiety disorder. In A Guide to Treatments that Work, ed. Nathan, P. E. & Groman, J. M., 2nd edn, pp. 337–65. New York: Oxford University Press.

Rynn, M. A., Siqueland, L. & Rickels, K. (2001). Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. The American Journal of Psychiatry, 158(12), 2008–14.Google Scholar

Rynn, M. A., Kunz, N. R. & Lamm, L. W. (2002). Venlafaxine XR for treatment of GAD in children and adolescents. Presented at the American Academy Child Adolescent Psychiatry Annual meeting, October 24, 2002 San Francisco, California.

Schoenfeld, F., Marmar, C. & Neylan, T. (2004). Current concepts in pharmacotherapy for Posttraumatic Stress Disorder. Psychiatric Services, 55, 519–31.Google Scholar

Scott, A., Shaw, M. & Joughin, C. (2001). Finding the Evidence: A Gateway to the Literature in Child and Adolescent Mental Health. London: Gaskell.

Simeon, J. G., Ferguson, H. B., Knott, V.et al. (1992). Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders. Journal of American Academy of Child and Adolescent Psychiatry, 31, 29–33.Google Scholar

Spence, S. H., Donovan, C. & Brechman-Toussaint, M. (2000). The treatment of childhood social phobia: the effectiveness of a social skills training-based cognitive-behavioural intervention, with and without parental involvement. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 41(6), 713–26.Google Scholar

Stein, B. D., Jaycox, L. & Kataoka, S.et al. (2003). A mental health intervention for schoolchildren exposed to violence: a randomised controlled trial. Journal of the American Medical Association, 290, 603–11.Google Scholar

Target, M. & Fonagy, P. (1996). The psychological treatment of child and adolescent psychiatric disorders. In What Works for Whom, ed. Roth, A. & Fonagy, P.. London: Guilford Press.

The Pediatric OCD Treatment Study (POTS) Team. (2004). Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the pediatric OCD treatment study (POTS) randomised controlled trial. Journal of the American Medical Association, 292(16), 1969–76.

Thienemann, M., Martin, J., Cregger, B., Thompson, H. B. & Dyer-Friedman, J. (2001). Manual-driven group cognitive-behavioural therapy for adolescents with obsessive-compulsive disorder: a pilot study. Journal of American Academy of Child and Adolescent Psychiatry, 1254–60.Google Scholar

Thomsen, P. H. (1997). Child and adolescent obsessive-compulsive disorder treated with citalopram: Findings from an open trial of 23 cases. Journal of Child and Adolescent Psychopharmacology, 7, 156–66.Google Scholar

Thomsen, P. H. (1998). Obsessive-compulsive disorder in children and adolescents. Clinical guidelines. European Child and Adolescent Psychiatry, 7, 1–11.Google Scholar

Trowell, J., Kolvin, I., Weeramanthri, T.et al. (2002). Psychotherapy for sexually abused girls: psychopathological outcome findings and patterns of change. British Journal of Psychiatry, 180, 234–47.Google Scholar

US Food and Drug Administration (2004). Antidepressant use in children, adolescents, and adults. October 15. Available at: http://www.fda.gov/cdept/drug/antidepressant/default.htm.

Varley, C. K. (2001). Sudden death related to selected tricyclic antidepressants in children: epidemiology, mechanisms and clinical implications. Paediatric Drugs, 3(8), 613–27.Google Scholar

Wagner, K. D., Cook, E. H., Chung, H. & Messig, M. (2003). Remission status after long-term sertraline treatment of pediatric obsessive-compulsive disorder. Journal of Child and Adolescent Psychopharmacology, 13(Suppl. 1), S53–60.Google Scholar

Waters, T. L., Barret, P. M. & March, J. S. (2001). Cognitive-behavioural family treatment of childhood obsessive-compulsive disorder: preliminary findings. American Journal of Psychotherapy, 55, 372.Google Scholar

Wetherhold, E. A., Carpenter, D. J. & Bailey, A. J. (2002). Efficacy of paroxetine in childhood and adolescent social anxiety disorder. Presented at the American Academy of Child and Adolescent Psych Annual meeting, October 24, 2002 San Francisco, California.

Book contents

57 - Anxiety disorders

Summary

Access options

References

Save book to Kindle

Save book to Dropbox

Save book to Google Drive